Nutriband Inc. Warrant
Symbol: NTRBW (NASDAQ)
3.00
▲ (20.48%) 0.510
Company Description:
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Key Stats
- Today's Open: $2.5
- Today's High: $3
- Today's Low: $2.5
- Today's Volume: 161
- Yesterday Close: $2.49
- Yesterday High: $2.49
- Yesterday Low: $2.3673
- Yesterday Volume: 4.48K
- Last Min Volume: 0
- Last Min High: $3
- Last Min Low: $2.583
- Last Min VWAP: $0
Company Profile
- Name: Nutriband Inc. Warrant
- Website: https://www.nutriband.com
- Listed Date: 2021-10-01
- Location: ORLANDO, FL
- Market Status: Active
- CIK Number: 0001676047
- SIC Code: 3842
- SIC description: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
- Market Cap: $
- Round Lot: 100
- Outstanding Shares:
- Asset Type: WARRANT
RECENT FILINGS FOR NTRBW
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 5 | View |
| 2025-10-20 | 424B3 | View |
| 2025-09-09 | 10-Q | View |
| 2025-09-03 | 8-K | View |
| 2025-08-07 | 8-K | View |
| 2025-07-16 | 8-K | View |
| 2025-07-08 | 424B4 | View |
| 2025-07-03 | EFFECT | View |
| 2025-07-03 | POS AM | View |
| 2025-06-23 | POS AM | View |
| 2025-05-30 | 10-Q | View |
| 2025-05-13 | 10-K/A | View |
| 2025-04-28 | 10-K | View |
| 2025-04-09 | 8-K | View |
| 2025-03-13 | SCHEDULE 13D | View |
| 2025-03-13 | SCHEDULE 13D | View |
| 2025-02-13 | 8-K | View |
| 2025-02-12 | 8-K | View |
| 2025-01-29 | 8-K | View |
| 2024-12-30 | 8-K | View |
Latest News on NTRBW